Asian Journal of Psychiatry
Volume 1, Issue 2 , Pages 47-49 , December 2008

Clozapine toxicity: A discussion of pharmacokinetic factors

Received 13 August 2008 ,Accepted 25 September 2008.

References 

  1. Bertilsson L, Carrillo J, Dahl ML, Llerna A, Alm C, Bondesson U, et al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Am. J. Psychiatry. 1994;38:471–473
  2. Carrillo JA, Herraiz AG, Ramos SI, Benitez J. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients. J. Clin. Psychopharmacol. 1998;18:311–316
  3. CLOZARIL (Clozapine) Novartis, 2001a. Physicians’ Desk Reference. 55, pp. 2042–2044.
  4. CLOZARIL (Clozapine) Novartis, 2001b. AHFS Drug Information, 27, pp. 1739–1742.
  5. Dequardo J, Roberts M. Elevated clozapine levels after fluvoxamine initiation (Letter). Am. J. Psychiatry. 1996;153:840–841
  6. Hiemke C, Weigmann H, Hartter S, Dahmen N, Wetzel H, Muller H. Elevated levels of clozapine in serum after addition of fluvoxamine. J. Clin. Psychopharmacol. 1994;14:279–281
  7. Johnson JA, Herring VL, Wolfe MS, Relling MV. CYP1A2 and CYP2D6 4-hydroxylates propranolol and both reactions exhibit racial differences. J. Pharmacol. Exp. Ther. 2000;294:1099–1105
  8. Khan AY, Preskorn SH. Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring. J. Psychiatr. Pract. 2005;11(5):289–301
  9. Naranjo CA, Busto U, Sellers P, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 1981;30:239–245
  10. Perry PJ, Miller DD, Arndt SV, Cadoret RJ. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am. J. Psychiatry. 1991;148:231–235
  11. Pirmohamed M, Williams D, Madden S, Templeton E, Park KB. Metabolism and bioactivation of Clozapine by human liver in vitro. J. Pharmacol. Exp. Ther. 1995;272:984–990
  12. Weigmann H, Muller H, Dahmen N. Interactions of fluvoxamine with the metabolism of clozapine (Letter). Am. J. Psychiatry. 1993;26:209

PII: S1876-2018(08)00028-2

doi: 10.1016/j.ajp.2008.09.001

Asian Journal of Psychiatry
Volume 1, Issue 2 , Pages 47-49 , December 2008

Article Tools